Is Your Compound Actually Therapeutic?

Translatable Insights with CETSA®  Translatable Insights with CETSA® on CDK4 and RIPK1 inhibitors, showcasing CETSA’s ability to track engagement from in vitro. Ensure your drug candidate’s efficacy with CETSA. This application note demonstrates how CETSA confirms target engagement across cell lines, animal models, and human primary cells—providing physiologically relevant insights that streamline drug discovery. Explore case studies models to in vivo systems. By validating target interaction early, CETSA helps reduce late-stage failures and accelerate development.  Download now to discover how CETSA can help you confidently select the right compound.